Suppr超能文献

检测严重急性呼吸综合征冠状病毒-2 在 2019 年冠状病毒病患者的眼泪中。

Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019.

机构信息

Ophthalmic Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Ophthalmology, Torfeh Medical Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Eye (Lond). 2020 Jul;34(7):1220-1223. doi: 10.1038/s41433-020-0965-2. Epub 2020 May 18.

Abstract

OBJECTIVES

Since there are few reports on the ocular involvement of coronavirus disease 2019 (COVID-19) patients, this study aimed to assess the presence of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) in the tears of patients with COVID-19.

METHODS

In this prospective case series, nasopharyngeal and tear sampling of 43 patients with severe COVID-19 were performed. The quantitative reverse transcription polymerase chain reaction (RT-PCR) was conducted to detect SARS-CoV-2. Ocular and systemic signs and symptoms were recorded from their medical history.

RESULTS

The mean age of patients was 56 ± 13 years. The average disease time from initiation of symptoms was 3.27 days, range: 1-7 days. Forty-one patients (95.3%) had fever at the time of sampling. Only one patient had conjunctivitis. Thirty (69.8%) nasopharyngeal and three (7%) tear samples were positive for SARS-CoV-2. The result of tear sample was positive in the patient with conjunctivitis. All patients with positive tear RT-PCR results had positive nasopharyngeal RT-PCR results.

CONCLUSIONS

Ocular manifestation was rare in this series of severe COVID-19 patients, however, 7% of the patients had viral RNA in their conjunctival secretions. Therefore, possibility of ocular transmission should be considered even in the absence of ocular manifestations.

摘要

目的

由于关于 2019 年冠状病毒病(COVID-19)患者眼部受累的报道较少,本研究旨在评估 COVID-19 患者的泪液中是否存在严重急性呼吸综合征冠状病毒-2(SARS-CoV-2)。

方法

在这项前瞻性病例系列研究中,对 43 例重症 COVID-19 患者进行了鼻咽和泪液采样。采用实时逆转录聚合酶链反应(RT-PCR)检测 SARS-CoV-2。从他们的病史中记录眼部和全身症状和体征。

结果

患者的平均年龄为 56±13 岁。症状开始后的平均发病时间为 3.27 天,范围为 1-7 天。41 名患者(95.3%)在采样时发热。仅有 1 名患者患有结膜炎。30 名(69.8%)鼻咽和 3 名(7%)泪液样本 SARS-CoV-2 阳性。结膜炎患者的泪液样本结果为阳性。所有 SARS-CoV-2 阳性的患者的鼻咽 RT-PCR 结果均为阳性。

结论

在这一系列重症 COVID-19 患者中,眼部表现罕见,但 7%的患者眼部分泌物中存在病毒 RNA。因此,即使没有眼部表现,也应考虑可能存在眼部传播。

相似文献

5
Evaluation of Conjunctival Swab PCR Results in Patients with SARS-CoV-2 Infection.评价 SARS-CoV-2 感染患者的结膜拭子 PCR 结果。
Ocul Immunol Inflamm. 2020 Jul 3;28(5):745-748. doi: 10.1080/09273948.2020.1775261. Epub 2020 Jun 22.
9
SARS-CoV-2 and the ocular surface: test accuracy and viral load.SARS-CoV-2 与眼表:检测准确性和病毒载量。
Arq Bras Oftalmol. 2023 Apr 3;87(5):e20220172. doi: 10.5935/0004-2749.2022-0172. eCollection 2023.

引用本文的文献

2
SARS-CoV-2 and the ocular surface: test accuracy and viral load.SARS-CoV-2 与眼表:检测准确性和病毒载量。
Arq Bras Oftalmol. 2023 Apr 3;87(5):e20220172. doi: 10.5935/0004-2749.2022-0172. eCollection 2023.
5
Ocular manifestations in COVID-19 infections: a case series.新型冠状病毒肺炎感染中的眼部表现:病例系列
Ann Med Surg (Lond). 2023 Sep 18;85(11):5309-5313. doi: 10.1097/MS9.0000000000001305. eCollection 2023 Nov.

本文引用的文献

7
2019-nCoV transmission through the ocular surface must not be ignored.2019新型冠状病毒通过眼表的传播不容忽视。
Lancet. 2020 Feb 22;395(10224):e39. doi: 10.1016/S0140-6736(20)30313-5. Epub 2020 Feb 6.
10
Many Faces of Renin-angiotensin System - Focus on Eye.肾素-血管紧张素系统的多面性——聚焦于眼部
Open Ophthalmol J. 2017 Jun 19;11:122-142. doi: 10.2174/1874364101711010122. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验